CCT4

CCT4 is the delta subunit of the cytosolic chaperonin TRiC/CCT, a hetero-oligomeric folding machine that processes cytoskeletal and signaling clients including actin, tubulin, mLST8, STAT3, and class I HDACs [PMID:18272176, PMID:35239512, PMID:35646538, PMID:bio_10.1101_2025.05.21.655272]. CCT4 is allosterically central to the complex: the G345D mutation abolishes both intra-ring and inter-ring cooperativity in ATP binding and disrupts actin organization and cell morphology, establishing that CCT-wide allostery depends on this subunit (PMID:18272176). Uniquely among CCT subunits, human CCT4 expressed alone assembles into homo-oligomeric back-to-back double rings that hydrolyze ATP and function as bona fide chaperonins, refolding luciferase and beta-actin and suppressing aggregation of gamma-D-crystallin and huntingtin; Cys450 is required for this oligomeric ring assembly (PMID:23612981, PMID:25124038). Through its substrate-folding activity CCT4 supports downstream signaling and survival programs: it folds mLST8 to sustain mTORC1/mTORC2 signaling, with its own translation driven by YB-1 binding the CCT4 mRNA 5'UTR (PMID:35239512); it folds STAT3 to maintain proteostasis in tumor cells (PMID:35646538); and it interacts with the APC/C activator Cdc20, so that its loss stabilizes APC/C substrates and triggers caspase-9-mediated apoptosis (PMID:34732665). Beyond the oligomeric complex, monomeric CCT4 promotes tunneling-nanotube formation and microtubule dynamics and is itself trafficked intercellularly (PMID:41104595). A C450Y missense mutation in rat Cct4 causes hereditary sensory neuropathy with loss of sensory ganglia, and the same substitution abolishes ring assembly in vitro, linking CCT4 folding competence to neuronal maintenance (PMID:12874111, PMID:25124038).

1. 1996 Low

   Before functional characterization, the basic genetics of Cct4 were defined to enable downstream study of its regulation.

   Evidence Genetic and YAC restriction mapping with allelic expression analysis in mouse

   PMID:8661059

   Open questions at the time

   • No functional mechanism established
   • Chromosomal location does not address protein activity or complex membership
2. 2003 Medium

   It was unknown whether a single CCT subunit defect produces a discrete in vivo phenotype; a rat Cct4 C450Y mutation causing hereditary sensory neuropathy showed that intact CCT4 is required for sensory neuron maintenance.

   Evidence Genetic mapping and candidate gene sequencing in a mutant rat strain

   PMID:12874111

   Open questions at the time

   • No in vitro reconstitution of the mutant protein at this stage
   • Mechanistic link between subunit defect and neuron loss not yet defined
3. 2008 High

   The role of CCT4 in chaperonin function was unresolved; a yeast G345D mutation showed that CCT4 is the allosteric linchpin governing cooperative ATP binding across the whole complex.

   Evidence Yeast ts-mutant kinetic ATP cooperativity assays plus actin/morphology phenotyping

   PMID:18272176

   Open questions at the time

   • Structural basis of the cooperativity defect not resolved
   • Does not address whether CCT4 has activity outside the hetero-oligomer
4. 2013 High

   Whether any single CCT subunit can fold substrates autonomously was unknown; human CCT4 alone was shown to form active homo-oligomeric chaperonin double rings.

   Evidence Recombinant E. coli expression, cryo-EM, ATPase and luciferase/crystallin refolding assays

   PMID:23612981

   Open questions at the time

   • Physiological relevance of homo-oligomers in cells not established
   • Client repertoire of homo-oligomer versus hetero-oligomer not delineated
5. 2014 High

   The mechanistic consequence of the neuropathy mutation was unknown; C450Y was shown to abolish ring assembly, connecting Cys450 to oligomerization and disease.

   Evidence Recombinant expression, negative-stain EM, beta-actin refolding and huntingtin aggregation assays

   PMID:25124038

   Open questions at the time

   • Effect of C450Y within native hetero-oligomeric TRiC not directly tested
   • Cellular consequences in sensory neurons not reconstructed
6. 2021 Medium

   A non-folding interaction of CCT4 was probed; CCT4 was found to bind Cdc20 and its loss stabilizes APC/C substrates to drive apoptosis.

   Evidence Co-IP and shRNA knockdown with Western blot and flow cytometry in hepatocellular carcinoma cells

   PMID:34732665

   Open questions at the time

   • Single Co-IP without reciprocal validation of the CCT4-Cdc20 interaction
   • Whether the effect requires folding activity or is direct on APC/C is unclear
7. 2022 Medium

   How CCT4 feeds into oncogenic signaling and how its own expression is controlled were open; CCT4 was shown to fold mLST8 to sustain mTOR signaling, with translation promoted by YB-1 binding its 5'UTR, and to fold STAT3.

   Evidence RIP, polysome profiling, reciprocal Co-IP, folding assays and xenografts (mLST8/mTOR); drug-target binding and STAT3 folding assays with xenografts

   PMID:35239512 PMID:35646538

   Open questions at the time

   • Structural detail of how CCT4/TRiC engages mLST8 and STAT3 not resolved
   • Generality beyond the tumor models tested not established
8. 2025 Medium

   Whether CCT4 has functions outside the oligomeric chamber was untested; monomeric CCT4 was shown to promote tunneling-nanotube formation and microtubule dynamics, and structural work captured a bent CCT4 conformation during HDAC folding.

   Evidence GFP-monomer constructs with live imaging and TNT/microtubule assays; cryo-EM and XL-MS of TRiC-HDAC complexes (preprint)

   PMID:41104595 PMID:bio_10.1101_2025.05.21.655272

   Open questions at the time

   • Monomer function reported by a single lab without independent replication
   • HDAC-folding structural model from an unreviewed preprint
   • Cellular abundance and regulation of free monomeric CCT4 not quantified

• How CCT4's distinct activities — hetero-oligomeric TRiC subunit, autonomous homo-oligomer, and free monomer — are partitioned and regulated within cells remains unresolved.
• No quantitative accounting of monomer vs oligomer pools in vivo
• Determinants of substrate selection across the different CCT4 forms unknown
• Structural mechanism linking allostery, ATP cooperativity, and substrate release incomplete